These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 14971874)
41. [TNF inhibitors for treatment of rheumatoid arthritis]. Otomo K; Koike T Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2405-12. PubMed ID: 19149036 [No Abstract] [Full Text] [Related]
42. Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy. Amano K Intern Med; 2006; 45(17):991-2. PubMed ID: 17015997 [No Abstract] [Full Text] [Related]
43. Reasons for Discontinuation and Adverse Effects of TNFα Inhibitors in a Cohort of Patients With Rheumatoid Arthritis and Ankylosing Spondylitis. García-Lagunar MH; Gutiérrez-Cívicos MR; García-Simón MS; Conesa-Zamora P; Jimenez-Santos E; Cano-Vivar P; García-Márquez A; Muñoz-García I; Viney AC Ann Pharmacother; 2017 May; 51(5):388-393. PubMed ID: 27920336 [TBL] [Abstract][Full Text] [Related]
44. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. Bongartz T; Sutton AJ; Sweeting MJ; Buchan I; Matteson EL; Montori V JAMA; 2006 May; 295(19):2275-85. PubMed ID: 16705109 [TBL] [Abstract][Full Text] [Related]
45. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Lee JH; Slifman NR; Gershon SK; Edwards ET; Schwieterman WD; Siegel JN; Wise RP; Brown SL; Udall JN; Braun MM Arthritis Rheum; 2002 Oct; 46(10):2565-70. PubMed ID: 12384912 [TBL] [Abstract][Full Text] [Related]
46. [Case of rheumatoid arthritis presenting with pulmonary tuberculosis]. Katoh K; Taniguchi H; Okouchi A; Kudo M; Kawai T Nihon Kokyuki Gakkai Zasshi; 2004 Aug; 42(8):782-6. PubMed ID: 15455955 [TBL] [Abstract][Full Text] [Related]
47. Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab. Fabre S; Gibert C; Lechiche C; Jorgensen C; Sany J J Rheumatol; 2005 Dec; 32(12):2432-3. PubMed ID: 16331777 [TBL] [Abstract][Full Text] [Related]
48. Guillain-Barré syndrome in a patient receiving anti-tumour necrosis factor alpha for rheumatoid arthritis: a case report and discussion of literature. Silburn S; McIvor E; McEntegart A; Wilson H Ann Rheum Dis; 2008 Apr; 67(4):575-6. PubMed ID: 18349168 [No Abstract] [Full Text] [Related]
50. Chronic inhibition of tumor necrosis factor-α with infliximab improves myocardial deformation in parallel with aortic elasticity in rheumatoid arthritis. Ay B; Vural MG; Ertem AG; Çağırcı G; Akdemir R; Efe TH; Keskin G; Yeter E Turk Kardiyol Dern Ars; 2015 Mar; 43(2):138-48. PubMed ID: 25782118 [TBL] [Abstract][Full Text] [Related]
51. Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis. Geraghty EM; Ristow B; Gordon SM; Aronowitz P Clin Infect Dis; 2007 May; 44(10):e82-4. PubMed ID: 17443458 [TBL] [Abstract][Full Text] [Related]
52. Infliximab: a review of its use in the management of rheumatoid arthritis. Markham A; Lamb HM Drugs; 2000 Jun; 59(6):1341-59. PubMed ID: 10882166 [TBL] [Abstract][Full Text] [Related]
53. High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis. Bobbio-Pallavicini F; Caporali R; Alpini C; Avalle S; Epis OM; Klersy C; Montecucco C Ann Rheum Dis; 2007 Mar; 66(3):302-7. PubMed ID: 17079248 [TBL] [Abstract][Full Text] [Related]
54. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Slifman NR; Gershon SK; Lee JH; Edwards ET; Braun MM Arthritis Rheum; 2003 Feb; 48(2):319-24. PubMed ID: 12571839 [TBL] [Abstract][Full Text] [Related]
55. Tumour necrosis factor blockade in rheumatoid arthritis. Breedveld FC Clin Med (Lond); 2001; 1(2):107-9. PubMed ID: 11333452 [No Abstract] [Full Text] [Related]
56. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Gómez-Reino JJ; Carmona L; Valverde VR; Mola EM; Montero MD; Arthritis Rheum; 2003 Aug; 48(8):2122-7. PubMed ID: 12905464 [TBL] [Abstract][Full Text] [Related]
57. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy. Danko JR; Gilliland WR; Miller RS; Decker CF Scand J Infect Dis; 2009; 41(4):252-5. PubMed ID: 19266397 [TBL] [Abstract][Full Text] [Related]
58. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Stokes MB; Foster K; Markowitz GS; Ebrahimi F; Hines W; Kaufman D; Moore B; Wolde D; D'Agati VD Nephrol Dial Transplant; 2005 Jul; 20(7):1400-6. PubMed ID: 15840673 [TBL] [Abstract][Full Text] [Related]